SCHEMBL20043029

SCHEMBL20043029

CCC1C(C(=O)OC)C(=O)CN1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.38
ALDH1A1 P00352 2/20 0.38
BRD4 O60885 1/20 0.34
MAPK1 P28482 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
PDE4B Q07343 1/20 0.33
CYP1A2 P05177 1/20 0.33
HIF1A Q16665 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 1/20 0.32
PKM P14618 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
NAMPT P43490 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
ATM Q13315 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2350221 0.75 NFKB1 (0.38) ALDH1A1MEN1KMT2AKDM4EDDB1
SCHEMBL18094061 0.73 PTPN1 (0.40) PTPN1ALDH1A1BRD4MAPK1NR1H2
SCHEMBL21561528 0.73 PTPN1 (0.40) PTPN1ALDH1A1BRD4MAPK1NR1H2
SCHEMBL3430499 0.73 PTPN1 (0.40) PTPN1ALDH1A1BRD4MAPK1NR1H2
SCHEMBL3430523 0.73 PTPN1 (0.40) PTPN1ALDH1A1BRD4MAPK1NR1H2
SCHEMBL2797179 0.73 NFKB1 (0.40) ALDH1A1MAPK1MEN1KMT2AKDM4E
SCHEMBL30674686 0.73 NFKB1 (0.40) ALDH1A1MAPK1MEN1KMT2AKDM4E
SCHEMBL38659661 0.73 HSD17B10 (0.37) ALDH1A1NR1H2NR1H3DDB1CRBN
SCHEMBL2500125 0.71 PTPN1 (0.41) PTPN1ALDH1A1NR1H2NR1H3CYP1A2
SCHEMBL7500751 0.70 NR1H2 (0.41) NR1H2NR1H3KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed